Source: Annual Congress 2013 –Immunopathology of COPD: contribution of advancements of new therapeutic agents
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. Timens (Groningen, Netherlands). Remodelling in the bronchi of patients with COPD: defective ECM deposition and repair by pulmonary fibroblasts. Annual Congress 2013 –Immunopathology of COPD: contribution of advancements of new therapeutic agents

Member's Comments

No comment yet.

Related content which might interest you: The senescence and impaired elastic synthesis in pulmonary fibroblasts from subjects with COPD Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD Year: 2010 Collagen V nasal tolerance reverts pulmonary immune cells proliferation and interstitium remodeling in experimental scleroderma Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Extracellular matrix molecules are differentially associated with airflow obstruction and lung parenchymal destruction in COPD Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD Year: 2019 Alveolar epithelial wound repair is delayed by scenescent lung fibroblasts in IPF Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019 Role of endothelin in lung fibrosis Source: Eur Respir Rev 2008; 17: 145-150 Year: 2008 Arterial remodelling in patients with idiopathic pulmonary fibrosis (IPF) and the possible role of endothelial to mesenchymal transition (EndMT) Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021 Epithelium involvement and remodeling of interstitium in idiopathic pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 745s Year: 2006 Remodelling of peripheral lung tissue in COPD Source: Eur Respir J 2008; 31: 913-914 Year: 2008 The role of altered stem cell function in airway and alveolar repair and remodelling in COPD Source: Eur Respir Monogr 2021; 91: 322-339 Year: 2021 Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD Source: Eur Respir J 2011; 38: 789-796 Year: 2011 Treprostinil effectively inhibits PDGF and TGF-ß1 induced extracellular matrix composition by IPF fibroblasts Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 Collagen content in human pulmonary emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 250s Year: 2001 Comparable matrix alterations in the alveolar and small airway wall of COPD patients Source: Annual Congress 2012 - Basic and translational studies in COPD Year: 2012 Inflammatory cells and airway remodelling in COPD Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications Year: 2019 NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFβ1-induced fibroblast differentiation into myofibroblasts Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung Year: 2009 Potential contribution of precursor cells to vascular remodeling in the AdTGF-β1 model of lung fibrosis and pulmonary hypertension Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 Does endostatin inhibit epithelial repair in idiopathic pulmonary fibrosis? Source: Eur Respir J 2006; 28: Suppl. 50, 337s Year: 2006 Fibrocyte accumulation in the airway walls of COPD patients Source: Eur Respir J, 54 (3) 1802173; 10.1183/13993003.02173-2018 Year: 2019 Epithelial mesenchymal transition in fibroblastic foci of different fibrosing lung diseases: Repair or remodeling? Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis Year: 2013 Pulmonary vascular remodelling in COPD versus bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 82s Year: 2003